- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Keloid in United Kingdom
Total 2385 results
-
University of Colorado, DenverBristol-Myers SquibbRecruiting
-
University of VirginiaRecruiting
-
Milton S. Hershey Medical CenterTakeda; Millennium Pharmaceuticals, Inc.TerminatedAcute Myeloid Leukemia (AML)United States
-
Massachusetts General HospitalBoehringer IngelheimWithdrawn
-
Memorial Sloan Kettering Cancer CenterTerminatedAcute Myeloid Leukemia (AML)United States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedAcute Myeloid Leukemia | AMLUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)WithdrawnRecurrent Acute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedSecondary Acute Myeloid Leukemia | Alkylating Agent-Related Acute Myeloid LeukemiaUnited States
-
Stanford UniversityVarian Medical Systems, Inc.RecruitingAcute Myeloid LeukemiaUnited States
-
University of Michigan Rogel Cancer CenterCompletedAcute Myeloid LeukemiaUnited States
-
Washington University School of MedicineKaryopharm Therapeutics IncCompletedAcute Myeloid LeukemiaUnited States
-
Duke UniversityAmerican Cancer Society, Inc.Completed
-
University of RochesterCompletedAcute Myeloid LeukemiaUnited States
-
University of California, San FranciscoCompletedAcute Myeloid LeukemiaUnited States
-
West Virginia UniversityCompleted
-
Washington University School of MedicineTerminatedLeukemia, Myeloid, AcuteUnited States
-
University of KansasNovartisCompletedAcute Myeloid LeukemiaUnited States
-
University of Colorado, DenverKaryopharm Therapeutics IncRecruitingAcute Myeloid Leukemia | Acute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia RefractoryUnited States
-
Daiichi Sankyo, Inc.CompletedAcute Myeloid LeukemiaUnited States, Spain, Netherlands, Canada, France, Germany, United Kingdom, Italy, Poland
-
Kartos Therapeutics, Inc.TerminatedRelapsed or Refractory Acute Myeloid Leukemia (AML) | Acute Myeloid Leukemia (AML), Secondary to Myeloproliferative Neoplasms (MPN)United States, Spain, Korea, Republic of, Belgium, United Kingdom, Hungary, France, Germany, Israel, Australia, Italy, Poland
-
H. Lee Moffitt Cancer Center and Research InstituteESP PharmaTerminatedAcute Myeloid Leukemia (AML)United States
-
Blueprint Medicines CorporationCompletedMast Cell Leukemia | Aggressive Systemic Mastocytosis | Systemic Mastocytosis-associated Hematologic Non-mast Cell Disease | Relapsed or Refractory Myeloid MalignanciesUnited States, United Kingdom
-
University of FloridaActive, not recruitingAcute Myeloid LeukemiaUnited States
-
Medical College of WisconsinActive, not recruitingAcute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterSeagen Inc.Terminated
-
Milton S. Hershey Medical CenterTerminatedAcute Myeloid LeukemiaUnited States
-
University of Colorado, DenverActive, not recruitingAcute Myeloid LeukemiaUnited States
-
Thomas Jefferson UniversityWithdrawnAcute Myeloid LeukemiaUnited States
-
Ayman H QasrawiAstellas Pharma IncWithdrawn
-
Medical College of WisconsinTerminatedLeukemia, Myeloid, AcuteUnited States
-
Michael BoyiadzisMerck Sharp & Dohme LLCCompletedAcute Myeloid LeukemiaUnited States
-
Annie Im, M.D.CompletedAcute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi CompanyCompletedAcute Myeloid LeukemiaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...TerminatedAcute Myeloid LeukemiaUnited States
-
Weill Medical College of Cornell UniversityGenzyme, a Sanofi CompanyCompletedAcute Myeloid LeukemiaUnited States
-
Massachusetts General HospitalWithdrawn
-
University of PittsburghTerminatedAcute Myeloid LeukemiaUnited States
-
University of PittsburghTerminatedAcute Myeloid LeukemiaUnited States
-
St. Jude Children's Research HospitalCompleted
-
Dutch Childhood Oncology GroupSt. Jude Children's Research Hospital; International BFM Study GroupCompletedAcute Myeloid LeukemiaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedSecondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Acute Myeloid Leukemia With FLT3/ITD Mutation | Acute Myeloid Leukemia With Gene Mutations | FLT3 Tyrosine Kinase Domain Point MutationUnited States
-
Syndax PharmaceuticalsRecruitingAcute Myeloid LeukemiasUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Untreated Adult Acute Myeloid LeukemiaUnited States
-
Yale UniversityVanderbilt UniversityCompletedRelapsed/Refractory Acute Myeloid LeukemiaUnited States
-
Arog Pharmaceuticals, Inc.CompletedPhase II Study of Crenolanib in Subjects With Relapsed/Refractory AML With FLT3 Activating MutationsRelapsed or Refractory Acute Myeloid Leukemia With FLT3 Activating MutationsUnited States
-
CicloMed LLCTerminatedRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
Fred Hutchinson Cancer CenterJazz PharmaceuticalsRecruitingAcute Myeloid Leukemia | Myeloid NeoplasmUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedUntreated Adult Acute Myeloid LeukemiaUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)WithdrawnUntreated Adult Acute Myeloid LeukemiaUnited States